We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Dow and out

19 Jun 2018 By Tom Buerkle

The charter member of the iconic benchmark stock average is being replaced by drugstore chain Walgreens due to slumping profit and a withering share price. It could make CEO John Flannery’s turnaround bid harder. Investors can only hope it will spark the radical changes GE needs.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)